LifeCycle Pharma starts head-to-head study of LCP-Tacro vs …Forbes, NY - 4 hours agoThe trial will be conducted as a head-to-head study versus Advagraf, an immunosuppressive agent launched in June this year by Astellas Pharma Co Ltd, …LifeCycle Pharma Initiates Head-to-Head Clinical Trial of LCP … Business Wire (press release)all 6 news articles
Read full story
Astellas Announces the Extension of US Regulatory Review for the …PipelineReview.com (press release), Spain - Sep 4, 2007Astellas pharma announced that its subsidiary, Astellas Pharma US has received notification from FDA that the action date under the Prescription Drug User …
Read full story
Danish shares close lower, led by Carlsberg, Novo Nordisk, Danske …Forbes, NY - 1 hour ago… in a head-to-head study versus Advagraf, which was launched in June this year by Astellas Pharma, Japan's third-largest drugmaker. …
Read full story
Glaxo's Avodart and Flomax Help Prostate, Study Says (Update1)Bloomberg - Sep 4, 2007Closely held Boehringer co-markets Flomax with Astellas Pharma Inc. of Japan. “We believe the data have demonstrated such benefit that we're filing them …Astellas Pharma - Google News
Read full story
FDA extends review for Astellas fungal drug new useReuters - 8 hours agoTOKYO, Sept 3 (Reuters) - US health authorities have extended by three months their review of Astellas Pharma Inc's (4503. …
Read full story
Cardiome And Astellas Announce Regulatory ExtensionCNNMoney.com - Aug 30, 2007Upon approval, vernakalant (iv) will be marketed in the United States by Astellas Pharma US, Inc., a US affiliate of Astellas Pharma Inc. In October 2003, …
Read full story
Astellas, Cardiome Heart Drug Gets Longer US Review (Update4)Bloomberg - Aug 30, 200730 (Bloomberg) — Cardiome Pharma Corp. and Astellas Pharma Inc. must supply additional information on their proposed treatment for irregular heart rhythms, …
Read full story
Cardiome, Astellas say new drug review extendedReuters Canada, Canada - Aug 30, 2007TO: Quote) and development partner Astellas Pharma said on Thursday that the US Food and Drug Administration has extended the review of their new drug …
Read full story
Cardiome Pharma says US FDA to extend review of heart drugCanada East, Canada - Aug 30, 2007The Vancouver-based drug developer and its partner Astellas Pharma US Inc. said the regulator has asked the companies to participate in a review by the …
Read full story
Cardiome to Meet With FDA PanelForbes, NY - Aug 30, 2007AP 08.30.07, 9:41 AM ET Drug developers Cardiome Pharma Corp. and Astellas Pharma US Inc. said Thursday the Food and Drug Administration asked the companies …
Read full story
Cardiome, Astellas Announce Regulatory ExtensionFDA news (subscription), VA - Aug 31, 2007Cardiome Pharma and its codevelopment partner Astellas Pharma announced that the FDA has requested that the companies participate in a panel review of …
Read full story
MediGene: European Approval Procedure For The Six-Months Dosage Of …Asia Corporate News Network (press release), Australia - Aug 30, 2007The drug is marketed by MediGene's licensee Astellas Pharma Europe Ltd. MediGene expects that the Eligard® revenue will meet the target projected for 2007. …
Read full story
Growing AF Market Players Still In Line: Who Will Lead?BioWorld Online, GA - Aug 28, 2007At the end of May, Cardiome's partner, Astellas Pharma Canada Inc., an affiliate of Astellas Pharma US Inc., filed a new drug submission with Health Canada …Astellas Pharma - Google News
Read full story
Astellas Pharma Announces Contents of Stock Acquisition Rights …PharmaLive.com (press release), PA - Aug 10, 2007Astellas Pharma Inc. Stock Acquisition Rights issued in August 2007 Besides above information, please refer to "Allotment of Stock Acquisition Rights (Stock …
Read full story
Cardiome Reports Second Quarter ResultsCanada NewsWire (press release), Canada - Aug 8, 2007Corporate Development The following significant events have occurred since our last quarterly report: << - In May 2007, we announced that Astellas Pharma …
Read full story
Cardiome Reports Second Quarter ResultsMSN Money - Aug 8, 2007In May 2007, we announced that Astellas Pharma Canada, Inc., an affiliate of our co-development partner, Astellas Pharma US, Inc., filed a New Drug …
Read full story
Ex-Searle Employees Feed Growing Chicago Life Sciences CommunityMidwestBusiness.com, IL - Aug 13, 2007It provides ongoing managerial expertise to not only all of the area’s major pharma companies (Abbott, Baxter, Takeda, Astellas, Hospira, etc. …
Read full story
Final programme announcedWebWire (press release), GA - 5 hours agoThe expert speaker line-up includes academics and practitioners from across Europe from companies including Altana Pharma, Analytica International, Astellas …
Read full story
Nikkei ends up 0.7 percent as property stocks gainReuters.uk, UK - Aug 2, 2007… Thursday as property stocks such as Mitsubishi Estate Co. gained on land price data and Japanese drug maker Astellas Pharma climbed on higher profits. …
Read full story
Asia Stocks Advance on Earnings; Taiwan Life, Mizuho DeclineBloomberg - Aug 2, 20072 (Bloomberg) — Asian stocks rose, recovering from earlier losses, after higher profits from Astellas Pharma Inc. and Chi Mei Optoelectronics Corp. helped …
Read full story